Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
ENLIVEN THERAPEUTICS, INC. (ELVN), most recent 12 months reported: net loss $105.93M, free cash flow -$70.46M. Latest balance sheet on file: liquid cash $895.15M. From SEC filings. More on ENLIVEN THERAPEUTICS, INC.: Profitability · Cash flow · Debt Others in Pharmaceutical Preparations: Dyne Therapeutics, Inc. · EDESA BIOTECH, INC. · Eledon Pharmaceuticals, Inc. · Elicio Therapeutics, Inc. · ENVERIC BIOSCIENCES, INC. · GALMED PHARMACEUTICALS LTD. · EUPRAXIA PHARMACEUTICALS INC. · EQUILLIUM, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.